Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal

Fig. 3

The ROC of independent variables and the AGH model for identifying moderate or severe inflammation or significant fibrosis in the validation set. The AUROC of the AGH model was 0.742, which was higher than that for AST (0.724), GGT (0.651) and Anti-HBC (0.609) alone in the validation set. AST, aspartate aminotransferase; Anti-HBC, anti-hepatitis B virus core antibody; GGT, glutamyl transpeptidase; ROC, the receiver operating characteristic curve;

Back to article page